Veeva Systems and Amgen Collaborate to Accelerate Innovation in Clinical Trials
Veeva Systems (NYSE: VEEV) today announced a strategic collaboration with global biotechnology leader Amgen to drive innovation in clinical...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Veeva Systems (NYSE: VEEV) today announced a strategic collaboration with global biotechnology leader Amgen to drive innovation in clinical...
Hong Kong, August 20, 2025 — Akeso, Inc. (9926.HK) has announced the enrollment and dosing of the first patient...
July 10, 2025 – The U.S. Food and Drug Administration (FDA) has approved BRAVECTO® QUANTUM (fluralaner for extended-release injectable...
August 7, 2025 – The U.S. Food and Drug Administration (FDA) has announced the launch of FDA PreCheck, a...
Research Triangle Park, NC & Pleasanton, CA – August 20, 2025 – After years of high-profile legal battles, life...
Mahwah, New Jersey, August 19, 2025 – Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
